CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 22 filers reported holding CANDEL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $746,798 | -27.0% | 811,737 | 0.0% | 0.22% | -27.1% |
| Q2 2023 | $1,022,789 | -6.7% | 811,737 | 0.0% | 0.30% | +11.8% |
| Q1 2023 | $1,095,845 | +75319.5% | 811,737 | 0.0% | 0.27% | -31.9% |
| Q4 2022 | $1,453 | -99.9% | 811,737 | 0.0% | 0.40% | -46.3% |
| Q3 2022 | $2,549,000 | -3.1% | 811,737 | 0.0% | 0.74% | +2.6% |
| Q2 2022 | $2,630,000 | -36.4% | 811,737 | 0.0% | 0.72% | -16.3% |
| Q1 2022 | $4,132,000 | -34.9% | 811,737 | 0.0% | 0.86% | -8.3% |
| Q4 2021 | $6,348,000 | -27.9% | 811,737 | 0.0% | 0.94% | -29.1% |
| Q3 2021 | $8,799,000 | – | 811,737 | – | 1.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 1,935,215 | $3,464,035 | 1.88% |
| Sands Capital Ventures, LLC | 811,737 | $1,453 | 0.40% |
| Empirical Asset Management, LLC | 12,000 | $21,480 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,700 | $237,533 | 0.01% |
| Ergoteles LLC | 26,114 | $46,744 | 0.00% |
| FRANKLIN RESOURCES INC | 1,125,000 | $2,013,750 | 0.00% |
| Tower Research Capital LLC (TRC) | 7,214 | $13 | 0.00% |
| WELLS FARGO & COMPANY/MN | 98 | $175 | 0.00% |
| NORTHERN TRUST CORP | 14,483 | $25,925 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |